XOMA Royalty (XOMA) Other Non Operating Income (2011 - 2026)
XOMA Royalty (XOMA) reported Other Non Operating Income of $4.8 million for Q1 2026, up 5110.53% on a YoY basis from $91353.5 in Q1 2025, and up 580.0% sequentially from $700000.0 in Q4 2025.
XOMA Royalty (XOMA) Other Non Operating Income (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Other Non Operating Income data on file, last reported at $4.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non Operating Income rose 5110.53% year-over-year to $4.8 million; the trailing twelve-month figure through Mar 2026 stood at $13.2 million (up 118.18% YoY), and the FY2025 full-year result was $93000.0, down 98.85% from the prior year.
- Other Non Operating Income grew to $4.8 million in Q1 2026, from $700000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $7.8 million in Q2 2025 to a low of -$215000.0 in Q1 2022.
- A 5-year average of $1.4 million and a median of $475500.0 in 2023 frame the typical range for Other Non Operating Income.
- Across the five-year window, Other Non Operating Income plunged 104.85% in 2025 and soared 5110.53% in 2026, its largest moves.
- Tracing XOMA's Other Non Operating Income over 5 years: stood at $219000.0 in 2022, then soared by 79.91% to $394000.0 in 2023, then surged by 458.38% to $2.2 million in 2024, then tumbled by 68.18% to $700000.0 in 2025, then soared by 580.0% to $4.8 million in 2026.
- Business Quant data shows XOMA's Other Non Operating Income at $4.8 million in Q1 2026, $700000.0 in Q4 2025, and $7.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 69,146.49 Bn | 69,146.20 Bn | - |
| 2 | Nanobiotix | 1,942.19 Bn | 1,942.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 475.42 Bn | 470.63 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.32 Bn | 116.08 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.80 Bn | 61.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.28 Bn | 63.28 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.48 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.15 Bn | 38.15 Bn | - |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.76 Mn |
| Dec 31, 2025 | 700,000.00 |
| Jun 30, 2025 | 7.82 Mn |
| Mar 31, 2025 | -95,000.00 |
| Dec 31, 2024 | 2.20 Mn |
| Sep 30, 2024 | 1.89 Mn |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 1.96 Mn |
| Dec 31, 2023 | 394,000.00 |
| Sep 30, 2023 | 278,000.00 |
| Jun 30, 2023 | 557,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | 219,000.00 |
| Sep 30, 2022 | 194,000.00 |
| Jun 30, 2022 | 97,000.00 |
| Mar 31, 2022 | -215,000.00 |
| Sep 30, 2021 | -1.09 Mn |
| Jun 30, 2021 | -300,000.00 |
| Mar 31, 2021 | -657,000.00 |
| Dec 31, 2020 | -821,000.00 |